Quasar Hospitals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.64 Cr
as on 16-11-2024
- Revenue 21.77%
(FY 2023)
- Profit 326.58%
(FY 2023)
- Ebitda 48.13%
(FY 2023)
- Net Worth 40.16%
(FY 2023)
- Total Assets 9.49%
(FY 2023)
About Quasar Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹26.64 Cr.
Vrajesh Shah, Sangeeta Shah, and Tanvi Shah serve as directors at the Company.
- CIN/LLPIN
U85110MH2005PTC151554
- Company No.
151554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Quasar Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vrajesh Shah  | Director | 24-Feb-2005 | Current |
| Sangeeta Shah | Director | 24-Feb-2005 | Current |
| Tanvi Shah | Director | 24-Sep-2022 | Current |
Financial Performance of Quasar Hospitals.
Quasar Hospitals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.77% increase. The company also saw a substantial improvement in profitability, with a 326.58% increase in profit. The company's net worth Soared by an impressive increase of 40.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quasar Hospitals?
In 2023, Quasar Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apex Superspeciality Hospitals Private LimitedActive 16 years 7 monthsVrajesh Shah, Sangeeta Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jun 2024 | ₹3.00 Cr | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 26 Jul 2019 | ₹1.00 Cr | Open |
Others Creation Date: 26 Jul 2019 | ₹7.50 M | Open |
How Many Employees Work at Quasar Hospitals?
Quasar Hospitals has a workforce of 83 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quasar Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quasar Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
